fda warning letters glp-1 october 2025 news Democratic lawmakers are pressing the Trump administration to disclose who received special access to Eli Lilly's investigational obesity drug retatrutide. Sen. Maggie Hassan (D-N.H.) sent a letter to HHS Secretary Robert F FDA Issues Warning Letters Against

Update on PCOS: consequences, challenges, and guiding treatment

Metabolic health improvements: 98% of patients improved at least one metabolic marker, and 78% of those with prediabetes or diabetes normalized their hemoglobin A1c levels at 12 months

To sugeruje istnienie dodatkowych, bezporednich mechanizmw dziaania lekw z tej grupy

When gut bacteria ferment fibre in the colon, they produce short-chain fatty acids (SCFAs) such as butyrate, propionate, and acetate, which directly stimulate GLP-1 release from intestinal L-cells

J., Nielsen, J

Plan coverage and prior authorization are required for all weight-loss medications